SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001802768-23-000023
Filing Date
2023-08-08
Accepted
2023-08-08 09:03:04
Documents
70
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rprx-20230630.htm   iXBRL 10-Q 2501471
2 EX-31.1 rprx-20230630ex311.htm EX-31.1 9255
3 EX-31.2 rprx-20230630ex312.htm EX-31.2 9291
4 EX-32 rprx-20230630ex32.htm EX-32 5011
  Complete submission text file 0001802768-23-000023.txt   9997079

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rprx-20230630.xsd EX-101.SCH 63061
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rprx-20230630_cal.xml EX-101.CAL 93286
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rprx-20230630_def.xml EX-101.DEF 344078
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rprx-20230630_lab.xml EX-101.LAB 658717
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rprx-20230630_pre.xml EX-101.PRE 444128
64 EXTRACTED XBRL INSTANCE DOCUMENT rprx-20230630_htm.xml XML 1732878
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39329 | Film No.: 231149549
SIC: 2834 Pharmaceutical Preparations